Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Clinical trial NCT03809481 · TERMINATED

Trial details

NCT number: NCT03809481
Sponsor: Aspen Global Incorporated
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Heparin-induced Thrombocytopenia

Start date: 2019-05-16
Primary completion: 2022-06-10
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.